EE200000151A - Aminoterminaalselt kärbitud rantes vormid, DNA molekulid, ekspressioonivektor, peremeesrakk, rekombinantne meetod proteiini valmistamiseks, proteiini kasutamine ning farmatseutiline kompositsioon - Google Patents

Aminoterminaalselt kärbitud rantes vormid, DNA molekulid, ekspressioonivektor, peremeesrakk, rekombinantne meetod proteiini valmistamiseks, proteiini kasutamine ning farmatseutiline kompositsioon

Info

Publication number
EE200000151A
EE200000151A EEP200000151A EEP200000151A EE200000151A EE 200000151 A EE200000151 A EE 200000151A EE P200000151 A EEP200000151 A EE P200000151A EE P200000151 A EEP200000151 A EE P200000151A EE 200000151 A EE200000151 A EE 200000151A
Authority
EE
Estonia
Prior art keywords
amino
pharmaceutical composition
host cell
production method
expression vector
Prior art date
Application number
EEP200000151A
Other languages
English (en)
Estonian (et)
Inventor
Proost Paul
Struyf Sofie
Van Damme Jo
Original Assignee
Applied Research Systems Ars Holding N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8227408&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200000151(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems Ars Holding N.V. filed Critical Applied Research Systems Ars Holding N.V.
Publication of EE200000151A publication Critical patent/EE200000151A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4813—Exopeptidases (3.4.11. to 3.4.19)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EEP200000151A 1997-09-29 1998-09-28 Aminoterminaalselt kärbitud rantes vormid, DNA molekulid, ekspressioonivektor, peremeesrakk, rekombinantne meetod proteiini valmistamiseks, proteiini kasutamine ning farmatseutiline kompositsioon EE200000151A (et)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP97116863A EP0906954A1 (fr) 1997-09-29 1997-09-29 C-C chémokine tronquée à l'aminoterminus comme antagoniste de chémokines
EP97122471A EP0905240A1 (fr) 1997-09-29 1997-12-19 Amino-terminale tronquée C-C chemokin et d'un antagoniste chemokin
EP98104216A EP0905241A1 (fr) 1997-09-29 1998-03-10 Amino-terminale tronquée C-C chemokine et d'un antagoniste de chemokin
PCT/EP1998/006143 WO1999016877A1 (fr) 1997-09-29 1998-09-28 Rantes tronques a acide amine terminal utilises comme antagonistes de la chemokine

Publications (1)

Publication Number Publication Date
EE200000151A true EE200000151A (et) 2001-02-15

Family

ID=8227408

Family Applications (2)

Application Number Title Priority Date Filing Date
EEP200000151A EE200000151A (et) 1997-09-29 1998-09-28 Aminoterminaalselt kärbitud rantes vormid, DNA molekulid, ekspressioonivektor, peremeesrakk, rekombinantne meetod proteiini valmistamiseks, proteiini kasutamine ning farmatseutiline kompositsioon
EEP200000152A EE200000152A (et) 1997-09-29 1998-09-28 Aminoterminaalselt kärbitud MCP-2 vormid, DNA molekulid, ekspressioonivektor, peremeesrakk, rekombinantne meetod proteiini valmistamiseks, proteiini kasutamine ning farmatseutiline kompositsioon

Family Applications After (1)

Application Number Title Priority Date Filing Date
EEP200000152A EE200000152A (et) 1997-09-29 1998-09-28 Aminoterminaalselt kärbitud MCP-2 vormid, DNA molekulid, ekspressioonivektor, peremeesrakk, rekombinantne meetod proteiini valmistamiseks, proteiini kasutamine ning farmatseutiline kompositsioon

Country Status (28)

Country Link
US (5) US6977071B2 (fr)
EP (6) EP0906954A1 (fr)
JP (2) JP4230659B2 (fr)
KR (2) KR100542934B1 (fr)
CN (3) CN1145693C (fr)
AR (2) AR013529A1 (fr)
AT (3) ATE368742T1 (fr)
AU (2) AU750341B2 (fr)
BG (2) BG64679B1 (fr)
BR (2) BR9812565A (fr)
CA (2) CA2304827A1 (fr)
CY (1) CY1110927T1 (fr)
CZ (2) CZ299478B6 (fr)
DE (3) DE69823218T2 (fr)
DK (3) DK1439231T3 (fr)
EA (2) EA003940B1 (fr)
EE (2) EE200000151A (fr)
ES (3) ES2215324T3 (fr)
HU (2) HU226414B1 (fr)
IL (2) IL135352A (fr)
NO (2) NO20001584D0 (fr)
NZ (3) NZ503235A (fr)
PL (2) PL197569B1 (fr)
PT (3) PT1021541E (fr)
SK (2) SK286495B6 (fr)
UA (2) UA73080C2 (fr)
WO (2) WO1999016877A1 (fr)
ZA (2) ZA988676B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6989435B2 (en) 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US7067117B1 (en) 1997-09-11 2006-06-27 Cambridge University Technical Services, Ltd. Compounds and methods to inhibit or augment an inflammatory response
WO1999028474A2 (fr) * 1997-12-01 1999-06-10 The Government Of The United States Of America, Represented By The Secretary Of Health And Human Services Variants de chemokine et leurs procedes d'utilisation
US7238711B1 (en) 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
EP1167527A1 (fr) * 2000-06-22 2002-01-02 Euroscreen S.A. Chemokines humaines tronquées: PHC-1 et PHC-2
DE60030749T2 (de) * 1999-10-25 2007-09-20 Pharis Biotec Gmbh Prozessiertes menschliches chemokin phc-1
WO2001036459A2 (fr) * 1999-11-15 2001-05-25 Forssmann Wolf Georg Nouvelle utilisation de hcc-2
CA2316405A1 (fr) * 2000-05-26 2001-11-26 Ian Clark-Lewis Modulation de l'inflammation a l'aide de produits du type protease
EP1176200A3 (fr) 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Utilisation des polypeptides ou leurs acides nucléiques pour le diagnose ou traitement des maladies de la peau ou de la cicatrisation de blessures et leurs utilisations pour l'identification des substances pharmacologiquement actives
UA77950C2 (en) * 2000-10-04 2007-02-15 Applied Research Systems Use of mutants of cc chemokines for treatment of multiple sclerosis
GB2373785A (en) * 2001-03-28 2002-10-02 Rega Inst For Medical Res Truncating chemokines using dipeptidyl peptidase IV
EP1458756B1 (fr) 2001-12-17 2009-01-28 Laboratoires Serono SA Mutants de chimiokines agissant en tant qu'antagonistes de chimiokines
WO2004104216A2 (fr) * 2003-05-21 2004-12-02 Bayer Healthcare Ag Diagnostics et agents therapeutiques destines a des maladies liees a une dipeptidylpeptidase iv (dpp4)
DE102005049637A1 (de) * 2005-10-14 2007-04-26 Rheinisch-Westfälische Technische Hochschule Aachen Antagonisten gegen die Interaktion von PF4 und RANTES
ES2453592T3 (es) 2007-08-02 2014-04-08 Novimmune Sa Anticuerpos anti-RANTES y métodos de uso de los mismos
US20130053257A1 (en) * 2010-02-08 2013-02-28 Paul E. Oran RANTES Multiplexed Assay, RANTES Variants Related to Disease, and RANTES Variants Related to Enzymatice Activity
CN102884194B (zh) 2010-03-11 2015-07-22 健康研究股份有限公司 含增强免疫应答的Fc融合蛋白的方法和组合物
TW201718851A (zh) * 2015-09-18 2017-06-01 通用醫院公司 具有抗化學排斥(anti-fugetactic)性質之經修飾自然殺手細胞及其用途
WO2019229615A1 (fr) 2018-05-28 2019-12-05 Université De Genève Méthodes d'inhibition de l'inflammation cérébrale
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions
US11402391B2 (en) 2020-12-21 2022-08-02 Incelldx, Inc. Methods of treating a long-hauler subject for chronic COVID-19 by administering a CCR5 or CCL5 antagonist

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01265099A (ja) 1987-10-08 1989-10-23 Stichting Rega Vzw 抗ｈｉｖ活性をもつ３’，−フルオロプリン−２’，３’−ジデオキシリボシド類
US5739103A (en) * 1993-11-12 1998-04-14 Dana-Farber Cancer Institute Chemokine N-terminal deletion mutations
FI972433A0 (fi) * 1994-12-08 1997-06-06 Glaxo Group Ltd Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoon soveltuvia koostumuksia
AU1532697A (en) * 1996-01-12 1997-08-01 Genetics Institute Inc. Beta-chemokine, h1305 (mcp-2)
JP2000508527A (ja) * 1996-03-27 2000-07-11 アイコス コーポレイション 単球走化性タンパク質―５物質及び方法
FR2748938B1 (fr) * 1996-05-22 1998-07-31 Pasteur Institut Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih
US6168784B1 (en) * 1997-09-03 2001-01-02 Gryphon Sciences N-terminal modifications of RANTES and methods of use

Also Published As

Publication number Publication date
EP1019507B1 (fr) 2004-03-31
PL339559A1 (en) 2000-12-18
CZ299478B6 (cs) 2008-08-06
JP2001518296A (ja) 2001-10-16
EA200000379A1 (ru) 2000-10-30
DE69838188T2 (de) 2007-11-22
SK4512000A3 (en) 2000-09-12
KR100542934B1 (ko) 2006-01-11
CN1148447C (zh) 2004-05-05
SK4502000A3 (en) 2000-09-12
KR100560275B1 (ko) 2006-03-10
AR013528A1 (es) 2000-12-27
CN1233415C (zh) 2005-12-28
EP1021541A1 (fr) 2000-07-26
AU750341B2 (en) 2002-07-18
EA003942B1 (ru) 2003-10-30
DK1439231T3 (da) 2007-11-05
CN1490049A (zh) 2004-04-21
EA003940B1 (ru) 2003-10-30
EP1439231A2 (fr) 2004-07-21
EA200000378A1 (ru) 2000-10-30
AU9442098A (en) 1999-04-23
SK286495B6 (sk) 2008-11-06
ZA988676B (en) 1999-12-03
PT1439231E (pt) 2007-08-20
AU750606B2 (en) 2002-07-25
BG64679B1 (bg) 2005-11-30
BG104267A (en) 2000-11-30
DE69822856T2 (de) 2004-08-19
CN1271386A (zh) 2000-10-25
HU226414B1 (en) 2008-11-28
SK286439B6 (sk) 2008-10-07
ES2215324T3 (es) 2004-10-01
US7326411B2 (en) 2008-02-05
BG104266A (en) 2000-11-30
UA73080C2 (en) 2005-06-15
CA2304827A1 (fr) 1999-04-08
ZA988675B (en) 1999-11-24
NO20001584L (no) 2000-03-27
NO20001584D0 (no) 2000-03-27
HK1062637A1 (en) 2004-11-19
CZ299479B6 (cs) 2008-08-06
ES2218860T3 (es) 2004-11-16
IL135351A (en) 2006-08-20
ES2287601T3 (es) 2007-12-16
US20050201977A1 (en) 2005-09-15
JP4233214B2 (ja) 2009-03-04
HK1032426A1 (en) 2001-07-20
NZ516027A (en) 2003-05-30
DE69822856D1 (de) 2004-05-06
US20050164936A1 (en) 2005-07-28
IL135352A (en) 2006-08-20
EP0906954A1 (fr) 1999-04-07
NZ503235A (en) 2002-08-28
PT1021541E (pt) 2004-07-30
PL197569B1 (pl) 2008-04-30
EP1439231A3 (fr) 2004-12-22
HUP0003563A3 (en) 2005-11-28
DK1021541T3 (da) 2004-08-02
HK1032425A1 (en) 2001-07-20
ATE264390T1 (de) 2004-04-15
CA2305017A1 (fr) 1999-04-08
AR013529A1 (es) 2000-12-27
JP4230659B2 (ja) 2009-02-25
CN1145693C (zh) 2004-04-14
US6977071B2 (en) 2005-12-20
KR20010024213A (ko) 2001-03-26
PL339545A1 (en) 2000-12-18
JP2001518297A (ja) 2001-10-16
EP1439231B1 (fr) 2007-08-01
KR20010024214A (ko) 2001-03-26
US20030119148A1 (en) 2003-06-26
US20050220790A1 (en) 2005-10-06
UA73081C2 (en) 2005-06-15
HUP0003505A2 (hu) 2001-02-28
DK1019507T3 (da) 2004-07-19
AU9747498A (en) 1999-04-23
DE69823218T2 (de) 2004-08-26
EP0905240A1 (fr) 1999-03-31
WO1999016877A1 (fr) 1999-04-08
EP0905241A1 (fr) 1999-03-31
US20030124677A1 (en) 2003-07-03
BR9812394A (pt) 2000-09-12
BR9812565A (pt) 2000-08-01
CZ20001147A3 (cs) 2000-09-13
HUP0003563A2 (hu) 2001-02-28
HU226468B1 (en) 2008-12-29
CY1110927T1 (el) 2015-06-10
EP1021541B1 (fr) 2004-04-14
US7338653B2 (en) 2008-03-04
HUP0003505A3 (en) 2005-11-28
BG64757B1 (bg) 2006-02-28
DE69823218D1 (de) 2004-05-19
PT1019507E (pt) 2004-06-30
WO1999016876A1 (fr) 1999-04-08
ATE368742T1 (de) 2007-08-15
NO20001609L (no) 2000-03-28
US6905676B2 (en) 2005-06-14
ATE263242T1 (de) 2004-04-15
NO20001609D0 (no) 2000-03-28
EP1019507A1 (fr) 2000-07-19
NZ503234A (en) 2002-06-28
CZ20001146A3 (cs) 2000-09-13
CN1271385A (zh) 2000-10-25
PL196427B1 (pl) 2008-01-31
DE69838188D1 (de) 2007-09-13
EE200000152A (et) 2001-02-15

Similar Documents

Publication Publication Date Title
EE200000151A (et) Aminoterminaalselt kärbitud rantes vormid, DNA molekulid, ekspressioonivektor, peremeesrakk, rekombinantne meetod proteiini valmistamiseks, proteiini kasutamine ning farmatseutiline kompositsioon
EP0760849A4 (fr) Proteines de recombinaison de type augmentant la permeabilite bactericide (bpi) et de type fixant le liposaccharide (lbd), molecules codant pour ces proteines, leurs procedes de production et leurs utilisations
EE200000355A (et) IFN/IFNAR kompleks ja vastav molekul ning nende kasutamine, DNA, peremeesrakk, liitvalgu valmistamismeetod, I tüüpi IFN säilimisaja pikendamise meetod, farmatseutiline kompositsioon ja IFNAR kasutamine
EP0749312A4 (fr) PROTEINES Gp29 DE -i(DIROFILARIA IMMITIS), MOLECULES D'ACIDE NUCLEIQUE ET LEURS UTILISATIONS
ZA9710163B (en) Novel carboxylesterase nucleic acid molecules, proteins and uses thereof.
FI971100L (fi) Menetelmä yhdistelmä-DNA-proteiinien, plasmidien ja modifioitujen solujen tuottamiseksi
NO981322L (no) Farmas÷ytiske preparater for bruk ved nukleinsyretransfeksjon, og deres anvendelse
AU7147898A (en) (dirofilaria) and (brugia) ankyrin proteins, nucleic acid molecules, and uses thereof
ATE435277T1 (de) 18477, eine menschliche proteinkinase und deren verwendung
IL138216A0 (en) Novel fdrg protein and nucleic acid molecules and uses therefor
ATE316138T1 (de) Rekombinante expression von s-layer-proteinen
EP0676413A3 (fr) Protéine liant l'interféron alpha/bêta, sa production et son application.
AU1818399A (en) Novel flea epoxide hydrolase nucleic acid molecules, proteins and uses thereof
ZA979390B (en) Polypeptides comprising domains of the GAX protein which are involved in the repression of transcription and/or which interact with other proteins, corresponding nucleic acids and their uses.
WO2001079525A3 (fr) Acides nucleiques et poypeptides purifies et isoles cotransporteurs de chlorure de potassium
AU5312699A (en) Novel mp-7 protein and nucleic acid molecules and uses therefor
EP1383877A4 (fr) Proteines enzymatiques humaines isolees, molecules d'acides nucleiques codant des proteines enzymatiques humaines, et utilisations associees
MXPA03005428A (es) Nuevas proteinas y moleculas de acido nucleico moduladoras del receptor de glutamato y uso de las mismas.
AU2001257287A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
EP1066310A4 (fr) Proteines et molecules d'acides nucleiques de neokine et leur utilisation
AU2002245128A1 (en) Human transporter proteins, nucleic acid molecules encoding them, and uses thereof
AU2001292769A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
AU2001288688A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2002223183A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2001292687A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner